Enduring products, enduring service

BOC Ophthalmic Instruments managing director TONY COSENTINO explains why he operates his distribution business on the knowledge that customers will ultimately remember him for the service, not the sale.

Read more

Prof Robyn Guymer to head up new 2RT study for iAMD

Adelaide-based Nova Eye Medical says it has navigated a time-consuming and complex series of conversations with the US Food and Drug Administration (FDA) to pave a clear approval pathway for its pioneering 2RT laser system for selected intermediate age-related macular degeneration (iAMD) patients. Read more

Bausch + Lomb eyes AU$1.2 billion in IPO

Ophthalmic giant Bausch + Lomb (B+L), which is being spun-off from its parent as a pure-play eye health company, has filed to raise up to US$840 million (AU$1.2 billion) in an initial public offering (IPO). Read more

© All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited